Efficacy of Exercise Snacks in Real-World Settings in Individuals Living With Type 2 Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To conduct a pilot randomized control trial to determine the feasibility of a 12-week, technology-enabled exercise snacks intervention in adults living with type 2 diabetes in a real-world setting. We will also assess preliminary efficacy based on measures of glycemic control and fitness.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 75
Healthy Volunteers: f
View:

• Aged 30-75 years.

• Have physician-diagnosed type 2 diabetes.

• Physically inactive (performing \<150 min moderate-to-vigorous physical activity per week).

• Body mass index: 18.5-40 kg/m2.

• Taking ≤3 glucose-lowering medications (excluding insulin) and stable dose for \> 6 months.

• Taking ≤2 commonly prescribed cardiovascular medications (e.g., statins, antihypertensive).

• HbA1c ≤8.5%.

• Able to maintain current physical activity patterns during the study.

• Cleared to engage in physical activity using the Get Active Questionnaire and, if applicable, consultation with a health care provider or Qualified Exercise Professional.

⁃ Access to a computer, tablet or smartphone for intervention delivery and tracking.

⁃ Ability to read and write in English.

Locations
Other Locations
Canada
University of British Columbia Okanagan
RECRUITING
Kelowna
Contact Information
Primary
Jonathan P Little, PhD
jonathan.little@ubc.ca
250.807.9876
Time Frame
Start Date: 2024-04-20
Estimated Completion Date: 2025-07-19
Participants
Target number of participants: 80
Treatments
Experimental: Exercise Snacks
Vigorous-intensity bodyweight exercises performed 4 times per day on at least 5 days per week.
Active_comparator: Placebo Exercise
Low-intensity stretching exercises performed 4 times per day on at least 5 days per week.
Related Therapeutic Areas
Sponsors
Collaborators: McMaster University
Leads: University of British Columbia

This content was sourced from clinicaltrials.gov